» Articles » PMID: 32734438

COVID-19 Among People Living with HIV: A Systematic Review

Overview
Journal AIDS Behav
Date 2020 Aug 1
PMID 32734438
Citations 108
Authors
Affiliations
Soon will be listed here.
Abstract

This systematic review summarizes the evidence on the earliest patients with COVID-19-HIV co-infection. We searched PubMed, Scopus, Web of Science, Embase, preprint databases, and Google Scholar from December 01, 2019, to June 1, 2020. From an initial 547 publications and 75 reports, 25 studies provided specific information on COVID-19 patients living with HIV. Studies described 252 patients, 80.9% were male, the mean age was 52.7 years, and 98% were on antiretroviral treatment (ART). Co-morbidities in addition to HIV and COVID-19 (multimorbidity) included hypertension (39.3%), obesity or hyperlipidemia (19.3%), chronic obstructive pulmonary disease (18.0%), and diabetes (17.2%). Two-thirds (66.5%) had mild to moderate symptoms, the most common being fever (74.0%) and cough (58.3%). Among patients who died, the majority (90.5%) were over 50 years old, male (85.7%), and had multimorbidity (64.3%). Our findings highlight the importance of identifying co-infections, addressing co-morbidities, and ensuring a secure supply of ART for PLHIV during the COVID-19 pandemic.

Citing Articles

Targeting mutation sites in the omicron variant of SARS-CoV-2 as potential therapeutic strategy against COVID-19 by antiretroviral drugs.

Erukainure O, Muhammad A, Ravichandran R, Abarshi M, Katsayal S, Abubakar M Toxicol Rep. 2024; 13:101825.

PMID: 39654998 PMC: 11626820. DOI: 10.1016/j.toxrep.2024.101825.


Relationships Among COVID-19-Related Service Uptake, HIV Status, Drug Use, and COVID-19 Antibody Status Among HIV Testing Intervention Participants in KwaZulu-Natal, South Africa.

Williams L, Memela P, van Heerden A, Friedman S, Joseph P, Chibi B Int J Environ Res Public Health. 2024; 21(11).

PMID: 39595678 PMC: 11593625. DOI: 10.3390/ijerph21111411.


Utilizing Feline Lentiviral Infection to Establish a Translational Model for COVID-19 in People with Human Immunodeficiency Virus Infection.

Shatnawi S, Gunasekara S, Bashor L, Tamil Selvan M, Nehring M, Cowan S Microorganisms. 2024; 12(7).

PMID: 39065058 PMC: 11278576. DOI: 10.3390/microorganisms12071289.


Clinical outcomes and immunological response to SARS-CoV-2 infection among people living with HIV.

Amegashie E, Asamoah P, Ativi L, Adusei-Poku M, Bonney E, Tagoe E Exp Biol Med (Maywood). 2024; 249:10059.

PMID: 38628843 PMC: 11020089. DOI: 10.3389/ebm.2024.10059.


Lost to follow up from chronic care services during COVID-19 from health facilities, in Northwest Ethiopia.

Belay D, Adugna A Front Epidemiol. 2024; 2:883316.

PMID: 38455279 PMC: 10910979. DOI: 10.3389/fepid.2022.883316.


References
1.
Pressman P, Clemens R, Sahu S, Wallace Hayes A . A review of methanol poisoning: a crisis beyond ocular toxicology. Cutan Ocul Toxicol. 2020; 39(3):173-179. DOI: 10.1080/15569527.2020.1768402. View

2.
Xu Y, Chen X, Wang K . Global prevalence of hypertension among people living with HIV: a systematic review and meta-analysis. J Am Soc Hypertens. 2017; 11(8):530-540. DOI: 10.1016/j.jash.2017.06.004. View

3.
Blanco J, Ambrosioni J, Garcia F, Martinez E, Soriano A, Mallolas J . COVID-19 in patients with HIV: clinical case series. Lancet HIV. 2020; 7(5):e314-e316. PMC: 7159872. DOI: 10.1016/S2352-3018(20)30111-9. View

4.
Livingston E, Bucher K . Coronavirus Disease 2019 (COVID-19) in Italy. JAMA. 2020; 323(14):1335. DOI: 10.1001/jama.2020.4344. View

5.
Zhu F, Cao Y, Xu S, Zhou M . Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China. J Med Virol. 2020; 92(6):529-530. PMC: 7228399. DOI: 10.1002/jmv.25732. View